stockrowFulgent Genetics, Inc. (FLGT) vs Freenome, Inc (FRNM)
- Fulgent Genetics, Inc. FLGT 18.66 −5.18%
- Freenome, Inc FRNM 10.47 −7.35%
Fulgent Genetics, Inc. and Freenome, Inc are both Diagnostics & Research companies. Freenome, Inc is the larger, with a market value of $1.1B against $513.4M — 2.2× the size. Freenome, Inc has the higher net margin (0.00% vs −27.5%) and the higher return on invested capital (0.00% vs −8.22%). Across the 11 metrics below, Freenome, Inc leads on 7 and Fulgent Genetics, Inc. on 4.
Valuation
Profitability
| Metric | FLGT | FRNM | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | — | 48.32% |
| Operating margin | (39.20%) | 0.00% | (5.68%) |
| Net margin | (27.53%) | 0.00% | (4.10%) |
| Free cash flow margin | 4.37% | 0.00% | 0.00% |
| Return on equity | (8.64%) | 17.81% | 0.00% |
| Return on assets | (7.93%) | (0.86%) | (6.05%) |
| Return on invested capital | (8.22%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack